Houttuynia cordata Polysaccharide Alleviates Hepatic Ischemia-Reperfusion Injury by Regulating Macrophage Polarization via Inhibiting the TLR4/NF-κB Signaling Pathway
Open Access
- 14 February 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 433
Abstract
Background: Hepatic ischemia-reperfusion injury (HIRI) is a major complication in liver surgery with limited therapeutic options. Houttuynia cordata polysaccharide (HCP), a key bioactive component of the traditional anti-inflammatory herb, has demonstrated immunomodulatory potential, but its effect on HIRI remains unclear. Methods: A murine model of 70% hepatic ischemia for 60 min followed by reperfusion was established. Mice were administered low-dose (50 mg/kg) or high-dose (100 mg/kg) HCP or the positive control N-acetylcysteine (150 mg/kg). Liver injury was assessed by serum ALT/AST levels, histopathology, oxidative stress markers, and inflammatory cytokines. Macrophage polarization and the TLR4/NF-κB pathway were analyzed using flow cytometry, qPCR, and Western blot. The TLR4 inhibitor TAK-242 was used for reverse validation, and molecular docking was performed to predict HCP binding to the TLR4/MD-2 complex. Results: HCP significantly attenuated HIRI-induced liver injury, as shown by reduced ALT/AST, improved histopathological scores, decreased MDA, increased SOD, and lower TNF-α and IL-6 levels. Mechanistically, HCP promoted a shift from M1 to M2 macrophage polarization, with increased CD206+ cells and Arg-1/IL-10 expression and decreased CD86+ cells and iNOS/IL-1β expression. HCP also suppressed TLR4/MyD88/NF-κB pathway activation, inhibiting NF-κB p65 phosphorylation and nuclear translocation. These protective effects were largely reversed by TAK-242 in vivo and in vitro. Molecular docking indicated stable binding between HCP and TLR4/MD-2. Conclusions: HCP protects against HIRI by targeting TLR4 to inhibit NF-κB signaling, thereby reprogramming macrophage polarization toward the M2 phenotype and alleviating inflammation and oxidative stress. These findings highlight HCP as a promising natural agent for HIRI intervention.Keywords
Funding Information
- National Natural Science Foundation of China (81870067)
- National Natural Science Foundation of China (82170664)
This publication has 18 references indexed in Scilit:
- Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patientsAmerican Journal of Transplantation, 2020
- Structural characterization and anti-A549 lung cancer cells bioactivity of a polysaccharide from Houttuynia cordataInternational Journal of Biological Macromolecules, 2018
- Neutrophils: a cornerstone of liver ischemia and reperfusion injuryLaboratory Investigation, 2018
- Macrophage Phenotype in Liver Injury and RepairScandinavian Journal of Immunology, 2016
- Thrombomodulin Attenuates Inflammatory Damage Due to Liver Ischemia and Reperfusion Injury in Mice in Toll-Like Receptor 4–Dependent MannerAmerican Journal of Transplantation, 2016
- The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human DiseasesOxidative Medicine and Cellular Longevity, 2016
- Global Consequences of Liver Ischemia/Reperfusion InjuryOxidative Medicine and Cellular Longevity, 2014
- Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of TransplantationLiver Transplantation, 2012
- Houttuynia cordata, a novel and selective COX-2 inhibitor with anti-inflammatory activityJournal of Ethnopharmacology, 2011
- Exploring the full spectrum of macrophage activationNature Reviews Immunology, 2008